PMID: 9547258Jun 20, 1998Paper

Accelerated mRNA decay in conditional mutants of yeast mRNA capping enzyme

Nucleic Acids Research
B SchwerS Shuman

Abstract

Current models of mRNA decay in yeast posit that 3' deadenylation precedes enzymatic removal of the 5' cap, which then exposes the naked end to 5' exonuclease action. Here, we analyzed gene expression in Saccharomyces cerevisiae cells bearing conditional mutations of Ceg1 (capping enzyme), a 52 kDa protein that transfers GMP from GTP to the 5' end of mRNA to form the GpppN cap structure. Shift of ceg1 mutants to restrictive temperature elicited a rapid decline in the rate of protein synthesis, which correlated with a sharp reduction in the steady-state levels of multiple individual mRNAs. ceg1 mutations prevented the accumulation of SSA1 and SSA4 mRNAs that were newly synthesized at the restrictive temperature. Uncapped poly(A)+ SSA4 mRNA accumulated in cells lacking the 5' exoribonuclease Xrn1. These findings provide genetic evidence for the long-held idea that the cap guanylate is critical for mRNA stability. The deadenylation-decapping-degradation pathway appears to be short-circuited when Ceg1 is inactivated.

References

Jan 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·C M Wei, B Moss
Mar 17, 1977·Nature·Y FuruichiA J Shatkin
Jan 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·Y FuruichiA J Shatkin
Jan 1, 1986·Annual Review of Biochemistry·S Lindquist
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M OhnoY Shimura
Dec 20, 1989·Journal of Molecular Biology·A J Davison, B Moss
Jan 1, 1988·Annual Review of Genetics·S Lindquist, E A Craig
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·I Edery, N Sonenberg
Dec 1, 1995·Genes & Development·S Z Tarun, A B Sachs
Nov 15, 1995·Molecular & General Genetics : MGG·M YamagishiA Ishihama
Mar 1, 1994·The Journal of Cell Biology·A JarmolowskiI W Mattaj
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·L D Fresco, S Buratowski
Aug 18, 1994·Nature·D Muhlrad, R Parker
May 13, 1994·Science·M P Terns, J E Dahlberg
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·B Schwer, S Shuman
Jul 1, 1996·Genes & Development·C SaavedraC N Cole
Jun 6, 1997·The Journal of Biological Chemistry·S P Wang, S Shuman
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·S P WangS Shuman
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S M FlahertyG M Gilmartin

❮ Previous
Next ❯

Citations

Jun 20, 2008·Chromosoma·Manfred Schmid, Torben Heick Jensen
Jan 12, 2011·Biochemistry·Andrew M L Lever, Kuan-Teh Jeang
Aug 14, 2008·Nature Reviews. Molecular Cell Biology·Michael D Cole, Victoria H Cowling
Nov 19, 2003·European Journal of Biochemistry·Alexey V Cherepanov, Simon de Vries
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sun Woo HongDong-Ki Lee
Aug 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Venkat S R K Yedavalli, Kuan-Teh Jeang
Aug 20, 2010·The Journal of Biological Chemistry·Man-Hee SuhJianhua Fu
Aug 30, 2007·AIDS Research and Human Retroviruses·Thomas M MeneesHans-Georg Kräusslich
Oct 6, 2000·Genes & Development·S C SchroederD Bentley
May 24, 2003·Cold Spring Harbor Symposia on Quantitative Biology·S Shuman
Sep 22, 2011·PloS One·Maude Tremblay-LétourneauMartin Bisaillon
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y WenA J Shatkin
Mar 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Elenita I KaninAseem Z Ansari
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·X WuM R Lieber
Nov 15, 2015·Expert Opinion on Therapeutic Patents·John Okombo, Kelly Chibale
Feb 6, 2016·Virologica Sinica·Yu Chen, Deyin Guo
Mar 21, 2009·Trends in Biochemical Sciences·Greco Hernández
Feb 5, 2008·Trends in Biochemical Sciences·Greco Hernández
Jul 1, 2010·Wiley Interdisciplinary Reviews. RNA·Agnidipta Ghosh, Christopher D Lima
May 20, 2005·Current Opinion in Cell Biology·Cyril SaguezTorben Heick Jensen
Dec 23, 2009·The Biochemical Journal·Victoria H Cowling
Dec 21, 2013·The Biochemical Journal·Thomas Gonatopoulos-Pournatzis, Victoria H Cowling
Apr 9, 2015·Asian Journal of Andrology·Jessie M SutherlandEileen A McLaughlin
Jan 21, 2004·Molecular Cell·Carme FabregaChristopher D Lima
Feb 18, 2004·Molecular Cell·Stephanie C SchroederDavid Bentley
Nov 7, 2002·Molecular Cell·Lawrence C MyersPaul Tempst
Mar 2, 2010·Molecular Cell·Silvia Jimeno-GonzálezTorben Heick Jensen
Nov 21, 2007·Cell·Meenakshi K Doma, Roy Parker
Dec 21, 2013·Virus Research·Benjamin W NeumanJeremiah Joseph
Aug 3, 2002·Nature Reviews. Molecular Cell Biology·Stewart Shuman
Jul 15, 2017·RNA Biology·Gesa Zander, Heike Krebber
Sep 13, 2018·Journal of Drug Targeting·Cong-Hui ZhangWu-Li Zhao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.